Grégoire Prévost - Concepedia

Author

Grégoire Prévost

Also Known As

G PREVOST, G Prevost, G Prévost, G. P. Prevost, G. Prevost, G. Prévost, G.P. Prevost, GRÉGOIRE PRÉVOST, Gregoire P. Prevost, Gregoire Pierre Prevost

132

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Ipsen (France)Inserm Centre National de la Recherche Scientifique Université Toulouse III - Paul Sabatier Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération

About

Grégoire Prévost is an author at Ipsen (France) specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	928
2	Biochemistry	7	7	409
3	Natural Sciences	6	6	328
4	Health Sciences	3	3	63
5	Engineering	2	2	71

Grégoire Prévost

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer Sylvia Julien, Ana Merino‐Trigo, Ludovic Lacroix, Clinical Cancer Research	2012	361
Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues Olivier Lavergne, Laurence Lesueur‐Ginot, Francesc Pla Rodas, Journal of Medicinal Chemistry Antitumor ActivityChemoprevention StrategyTumor Growth DelayHeterocycle ChemistryPharmaceutical Chemistry	1998	150
Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma Negar Babae, Meriem Bourajjaj, Yijia Liu, Oncotarget	2014	118
Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. Muriel Duran Cordobes, Anna Starzec, Laurence I. Delmon-Moingeon, PubMed	1996	117
Autocrine Induction of Invasive and Metastatic Phenotypes by the MIF-CXCR4 Axis in Drug-Resistant Human Colon Cancer Cells Anne‐Frédérique Dessein, Laurence Stechly, Nicolas Jonckheere, Cancer Research	2010	108
Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. Jacques Epelbaum, Jérôme Bertherat, Grégoire Prévost, The Journal of Clinical Endocrinology & Metabolism Pharmacological CharacterizationPathologyTumor BiologyMolecular PharmacologyAdrenal Gland	1995	83
Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on Gα Subunit Mohammed Akli Ayoub, Marjorie Damian, Christian Gespach, Journal of Biological Chemistry Molecular RegulationG Protein HeterotrimerSmall Molecule ActingCell SignalingMolecular Signaling	2009	75
Inhibition of human tumor cell growth <i>in vivo</i> by an orally bioavailable inhibitor of CDC25 phosphatases Marie-Christine Brézak, Muriel Quaranta, Marie-Odile Contour-Galcéra, Molecular Cancer Therapeutics	2005	65
A Novel Synthetic Inhibitor of CDC25 Phosphatases Marie-Christine Brézak, Muriel Quaranta, Odile Mondésert, Cancer Research	2004	64
Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric Gα/Gβγ Protein Complex Grégoire Prévost, M. O. Lonchampt, Susan L. Holbeck, Cancer Research Molecular PharmacologyMedicinal ChemistryChemoprevention StrategyNovel TherapyG Protein-coupled Receptor	2006	61

Page 1